TEKLA CAPITAL MANAGEMENT LLC – Cytokinetics, Incorporated Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$3.64M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+23.31%
quarter
Cytokinetics, Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -37.33% | -44.75K shares | -1.07M | $48.45 | 75.13K |
| Q2 2022 | share | 0.00% | 0 shares | 298K | $39.29 | 119.89K | |
| Q1 2022 | share | Increase | +29.10% | 27.02K shares | 180K | $36.81 | 119.89K |
| Q4 2021 | share | Increase | 0.00% | 92.87K shares | 4.23M | $45.6 | 92.87K |
| Q2 2018 | share | Decrease | -100.00% | -137.79K shares | -992K | $8.3 | 0 |
| Q1 2018 | share | Decrease | -60.66% | -212.50K shares | -1.86M | $7.2 | 137.79K |
| Q4 2017 | share | Increase | 0.00% | 350.3K shares | 2.85M | $8.15 | 350.3K |